Brown & Brown (BRO) drew attention after reporting first quarter results with 35.4% total revenue growth and a higher EBITDAC margin, while continuing to integrate its Accession acquisition and expand the use of technology and AI.

Despite the strong quarter and emphasis on technology and AI, Brown & Brown’s momentum has cooled, with the share price down 21.9% over 90 days and total shareholder return declining 47.4% over one year.

If this kind of reset has you looking beyond insurance brokers, it could be a good moment to scan the market for other ideas using our 21 top founder-led companies

So with revenue and net income still growing, a sizeable discount to one valuation estimate, and a sharp pullback in the share price, should you view Brown & Brown as mispriced value or assume the market is already factoring in its future growth potential?

Most Popular Narrative: 21.4% Undervalued

With Brown & Brown last closing at $57.38 against a narrative fair value of $73, the current pullback sits in sharp contrast to that valuation story.

Strong cash flow from operations, combined with a strategic focus on leveraging a diversified portfolio across geographies and lines of business, positions the company to navigate economic uncertainties and potentially increase future earnings stability and growth.

Curious what is behind that projected fair value gap? The narrative focuses on steady revenue expansion, resilient margins and a richer earnings multiple than the sector usually commands.

Result: Fair Value of $73 (UNDERVALUED)

However, there are pressure points to watch, including potential earnings strain from lower CAT property rates and rising pharmacy costs that could squeeze employee benefits margins.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another Way Of Looking At It

Those fair value estimates around $73 sit alongside a different message from the market. Brown & Brown trades on a P/E of 17.1x, which is higher than the US Insurance industry at 10.3x and above a fair ratio of 11.9x, so the stock carries clear valuation risk if that gap closes.

That same 17.1x P/E is below a 25.9x peer average though, which points to investors placing Brown & Brown somewhere between an industry workhorse and a premium peer. The question is whether you think the business belongs closer to the lower industry anchor or the higher peer group, and what that means for your margin of safety relative to the fair ratio and current price level. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With a mix of confidence around cash flows and concern about valuation and earnings pressure, sentiment on Brown & Brown is clearly split. It may help to move quickly and weigh the trade off yourself using the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If Brown & Brown has you rethinking your portfolio mix, now is the time to widen your search and line up a few fresh candidates.

• Spot potential value opportunities early by scanning our list of 47 high quality undervalued stocks before other investors start paying closer attention.
• Strengthen your focus on financial resilience by checking companies in the solid balance sheet and fundamentals stocks screener (46 results) and see which stocks may handle tougher conditions more comfortably.
• Give yourself a chance to uncover less crowded opportunities by reviewing the screener containing 22 high quality undiscovered gems before they hit everyone else's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.